| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical Inc. (RARE) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 24 sells. RARE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 147.8K | $3.74M | - | |
| Other | 133.1K | $3.37M | - | |
| CEO | 132.7K | $3.36M | - | |
| CFO | 105.7K | $2.68M | - | |
| VP | 95.7K | $2.42M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2017 | Sharp Shalini | CFO &Executive Vice President | Sale+OE | 12,000 | $90.10 | $1,081,176.00 | -17.7% | |
| Feb 27, 2017 | Sharp Shalini | CFO &Executive Vice President | Sale+OE | 12,000 | $80.14 | $961,680.00 | -18.8% | |
| Dec 5, 2016 | Aliski William | Director | Sale+OE | 6,000 | $78.19 | $469,160.00 | -4.7% | |
| Nov 16, 2016 | Huizenga Theodore Alan65 | Controller And Pao | Sale+OE | 2,000 | $79.73 | $159,460.00 | -15.2% | |
| Nov 15, 2016 | Kakkis Emil D72 | President &CEO | Sell | 20,000 | $81.29 | $1,625,753.15 | -0.9% | |
| Nov 9, 2016 | Sharp Shalini | CFO &Executive Vice President | Sale+OE | 24,000 | $71.20 | $1,708,893.65 | -8.8% | |
| Oct 19, 2016 | Sharp Shalini | CFO &Senior Vice President | Sale+OE | 12,000 | $61.40 | $736,820.36 | -10.9% | |
| Oct 14, 2016 | Kakkis Emil D72 | President &CEO | Sell | 20,000 | $63.02 | $1,260,360.40 | -1.0% | |
| Aug 15, 2016 | Kakkis Emil D72 | President &CEO | Sell | 20,000 | $67.61 | $1,352,250.81 | -2.0% | |
| Jul 21, 2016 | Agarwal Sunil | Chief Medical Officer | Sell | 649 | $52.68 | $34,189.32 | -6.4% |